Navigation Links
Kensey Nash Corporation Announces Achievement of $6 Million Milestone From Spectranetics Corporation
Date:12/12/2011

EXTON, Pa., Dec. 12, 2011 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) today announced that it was recently informed by Spectranetics Corporation (Nasdaq: SPNC) that they reached a cumulative $20 million in end-user sales of the endovascular product lines purchased from Kensey Nash in May 2008. Accordingly, this triggered achievement of a $6 million milestone payable to Kensey Nash.  As previously disclosed, the Company expects to record approximately $5 million as revenue for the three months ending December 31, 2011, and the remainder will be deferred and recognized as revenue over the next year. The $6 million cash payment is expected to be received in February 2012.

About Kensey Nash Corporation.  Kensey Nash Corporation is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technologies.  The Company is recognized as a leader for innovative product development and unique technology in the field of resorbable biomaterials.  The Company has an extensive range of products which are sold through strategic partners in multiple medical markets, including the cardiology, orthopaedic, sports medicine, spine, endovascular and general surgery markets.  For more information, visit www.kenseynash.com.


'/>"/>
SOURCE Kensey Nash Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Kensey Nash Reports Second Quarter Fiscal Year 2011 Financial Results
2. Kensey Nash to Present at the 2009 UBS Global Life Sciences Conference
3. Synthes and Kensey Nash Announce Strategic Agreement for Extracellular Matrix Products
4. Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product
5. Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results
6. Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
7. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2012 Financial Results
8. United Therapeutics Corporation Reports Third Quarter 2011 Financial Results
9. United Therapeutics Corporation to Announce Third Quarter 2011 Financial Results Before Market Open on Thursday, October 27, 2011
10. China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 19, 2011
11. Luminex Corporation Joins Forces With the National Marrow Donor Program - Be The Match®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Newly ... technologies, services and solutions to the healthcare market. The company's primary focus is ... manufacturing, sales and marketing strategies that are necessary to help companies efficiently bring ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 ... a product subsidiary of Infosys (NYSE: ... to integrate the Onegini mobile security platform with ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration will ... to access and transact across channels. Using this ...
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
Breaking Biology News(10 mins):